Adjuvant Systemic Therapies in Patients with Colorectal Cancer: An Audit on Clinical Practice in Italy

Autor: F. Recchia, P. Marchei, R. Trevisonne, C. Pizza, S. Chiadò Cutin, M. Tonato, S. Del Prete, G. Vietti Ramus, C. Oliva, T. Iannone, Mario Roselli, V. Bortolussi, F. Nigro Imperiale, S. Venuta, V. Angelini, S. Cascinu, C. Volta, M. Musi, V. Guardasole, R. Ferraldeschi, L. Isa, Stefano Cascinu, F. Cognetti, M.L. Evangelista, E. Biondi, M.P. Sirgiovanni, C. Modenesi, V. Gebbia, D. Santini, E. Greco, E. Ferrazzi, M. Betti, F. Verderame, C. Bumma, G. Cicero, G. Pieri, G. Nastasi, A. Pessi, L. Patoia, S. Palazzo, M. Belli, C. Di Fonzo, Giuseppe Colucci, S. Cigolari, G. Fornarini, F. Ferraù, G. Rosati, A. Nuzzo, G. Porcile, P. Sozzi, A. Mozzicafreddo, M. Chetrì, B. Massidda, G. Luporini, A. Lembo, R. Carroccio, F. Testore, Enzo Ballatori, V. Bon-ciarelli, G. Ausili Cefaro, P. Marchetti, P. Berniolo, G. Filippelli, Enrico Cortesi, Salvatore Palazzo, A. Prosperi, G. Citone, M. Cremonesi, A. Peta, G. Rimondi, Giorgio Mustacchi, Francesco Di Costanzo, F. Marrocolo, R. Laricchiuta, R. Maurizi Enrici, D. Perrone, G. P. Iannello, Fausto Roila, A. Lavarello, L. Manzione, V. Lacava, G. Solina, P. Manente, A. Cioffi, R. Ceccherini, V. Sidoti, V. Picece, E. Recaldin, V. Tinessa, P. Giordani, M. D'Aprile, O. Bertetto, M. D'Amico, M. Serlenga, E. Vigevani, M. Mazzoli, Giovanni Mantovani, P. Marsilio, P. Rizzo, V. Mascia, G. Tonini, G. Carteni, Alberto Sobrero, B. Daniele, L. Milesi, Benedetta Ruggeri, G. Margutti, M. Botturi, M. Nicodemo, V. Silingardi, C. Iacono, A. Comandone, G. Colucci, P. Alessandroni, E. Zarra, G. Beretta, G. Reguzzoni, M. Turaz-za, L. Tonda, A. Rossi, G. Troccoli, S. Mosconi, G. Catalano, S. Bretti, T. Prantera, M. Destefanis, A. Sobrero, G. Cruciani, V. Sciacca, M. Marzola, P. Malacarne, M. Mandalà, L. Montalbetti, G. Tuveri, A Ruggiero, A. Zaniboni, G. Cetto, S. Spada, S. Barni, Roberto Labianca, C. Caroti, M.T. Ionta, C. Bressi

Publikováno v: Tumori Journal. 91:472-476

Aims and Background Rarely are conclusions from clinical trials summarized in international consensus conferences and promptly transferred to patient care. The adjuvant therapy for colorectal cancer used in daily clinical practice in Italy is describ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8d0a699e849d960b649a6a8bece6fa4
https://doi.org/10.1177/030089160509100605

Delayed emesis induced by moderately emetogenic chemotherapy: Do we need to treat all patients?

Autor: O. Daniele, Andrea Lissoni, A. Antonuzzo, A. Maestri, P. Anastasi, Arcispedale S. Anna Ferrara, C. Basurto, Stefano Cascinu, S. Ramponi, M. Tagliaventi, V. Silingardi, E. Mantellim, G. Scagliotti, Fausto Roila, S. Ricci, D. Donati, F. Meriggi, M. Tonato, R. Tonachella, F. Di Costanzo, A. Santoro, M. Federico, E. Riva, P. Malacarne, Francesco Cognetti, A. Fabi, S. Tateo, M. Picciafuoco, A. D'Antona, G. Ferretti, A. Del Favero, F. Salvati, C. Boni, F. Nunziati, V. Ferraresi, M. A. Palladino, A. M. Mosconi, R. Sabbatini, Silvana Chiara, P. Zucchinelli, Elisabetta Campora, A. Antilli, A. Zaniboni, Pierfranco Conte, P. Barbian, G. Moretti, M. C. Locatelli, Enrico Cortesi, Giacomo Allegrini, V. De Angelis, G. Catalano, A. Trassoldati, S. Cirulli, Enzo Ballatori, G. Ciccarese

Publikováno v: Annals of Oncology. 8:561-567

Summary Background The pattern and prognostic factors of delayed nausea and vomiting induced by moderately emetogenic chemotherapy have not yet been adequately studied. Patients and methods Data are derived from a large and well defined population of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8bf8f3091e2d3f7928a3a72eed02162a
https://doi.org/10.1023/a:1008229721099

A Multicenter Randomized Trial of Two Different ProMACE-CytaBOM Derived Protocols in Aggressive Non-Hodgkin's Lymphomas (NHL). A Preliminary Report

Autor: M. Lombardo, V. Silingardi, N. Di Renzo, M. Brugiatelli, P. G. Gobbi, C. Mauri, Franco Narni, L. Baldini, L. Cavanna, G. Nicoletti, A. La Sala, G. Longo, Mario Carotenuto, V. Iannitto, Paolo Avanzini, Massimo Federico

Publikováno v: Leukemia & Lymphoma. 7:25-28

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c061bb7fdd749ab8cc0a3a16850d0949
https://doi.org/10.3109/10428199209058649

LONG-TERM RESULTS FROM MOPPEBVCAD CHEMOTHERAPY WITH OPTIONAL LIMITED RADIOTHERAPY IN ADVANCED HODGKIN'S DISEASE

Autor: P G, Gobbi, C, Pieresca, M L, Ghirardelli, N, Di Renzo, M, Federico, F, Merli, E, Iannitto, V, Pitini, G, Grignani, A, Donelli, M, Carotenuto, V, Silingardi, E, Ascari

The purpose was to verify the 5-year results of the MOPPEBVCAD chemotherapy regimen with limited radiotherapy in relation to the promising preliminary data. Mechlorethamine, vincristine, procarbazine, prednisone, epidoxorubicin, bleomycin, vinblastin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b113bea15da1b02b1b93bbf3181222bc
http://hdl.handle.net/11570/1873680

Multifocal leukoencephalopathy associated with 5-fluorouracil and levamisole adjuvant therapy for colon cancer. A report of two cases and review of the literature. The INTACC. Intergruppo Nazionale Terpia Adiuvante Colon Carcinoma

Autor: G, Luppi, A, Zoboli, F, Barbieri, G, Crisi, L, Piccinini, V, Silingardi

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 7(4)

Since 1990 the combination of 5-fluorouracil plus levamisole has been considered the standard therapy for stage B2-C resected colon cancer in the adjuvant setting. Since 1992, 14 cases of multifocal leukoencefalopathy following 5-fluorouracil and lev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0532321ddd6f33625ce719f35de00946
https://pubmed.ncbi.nlm.nih.gov/8805935